Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (FPHAF) Stock Competitors & Peer Comparison
See (FPHAF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FPHAF | $3.30 | +0.00% | 209.5M | -7.50 | -$0.44 | N/A |
| NONOF | $40.27 | -16.97% | 214.8B | 13.21 | $3.66 | +3.58% |
| CSLLY | $52.07 | -3.62% | 104.7B | 17.56 | $3.08 | +2.51% |
| UCBJF | $340.04 | +0.00% | 64.3B | 41.50 | $8.15 | +0.47% |
| UCBJY | $159.38 | -4.61% | 62B | 40.08 | $4.07 | +0.48% |
| CMXHF | $103.43 | -3.39% | 50.7B | 16.95 | $6.17 | +2.79% |
| ARGNF | $814.94 | +0.00% | 50.4B | 34.81 | $23.41 | N/A |
| WXIBF | $5.25 | +0.00% | 21.7B | 37.50 | $0.14 | N/A |
| WXXWY | $10.66 | +2.95% | 21.4B | 37.63 | $0.28 | N/A |
| IVBXF | $11.40 | -0.87% | 19.8B | 115.00 | $0.10 | N/A |
Stock Comparison
FPHAF vs NONOF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NONOF has a market cap of 214.8B. Regarding current trading prices, FPHAF is priced at $3.30, while NONOF trades at $40.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NONOF's P/E ratio is 13.21. In terms of profitability, FPHAF's ROE is +0.00%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, FPHAF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NONOF's competition here
FPHAF vs CSLLY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSLLY has a market cap of 104.7B. Regarding current trading prices, FPHAF is priced at $3.30, while CSLLY trades at $52.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSLLY's P/E ratio is 17.56. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, FPHAF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CSLLY's competition here
FPHAF vs UCBJF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJF has a market cap of 64.3B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJF trades at $340.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJF's P/E ratio is 41.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to UCBJF's ROE of +0.14%. Regarding short-term risk, FPHAF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJF's competition here
FPHAF vs UCBJY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJY has a market cap of 62B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJY trades at $159.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJY's P/E ratio is 40.08. In terms of profitability, FPHAF's ROE is +0.00%, compared to UCBJY's ROE of +0.14%. Regarding short-term risk, FPHAF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJY's competition here
FPHAF vs CMXHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMXHF has a market cap of 50.7B. Regarding current trading prices, FPHAF is priced at $3.30, while CMXHF trades at $103.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMXHF's P/E ratio is 16.95. In terms of profitability, FPHAF's ROE is +0.00%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, FPHAF and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
FPHAF vs ARGNF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ARGNF has a market cap of 50.4B. Regarding current trading prices, FPHAF is priced at $3.30, while ARGNF trades at $814.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ARGNF's P/E ratio is 34.81. In terms of profitability, FPHAF's ROE is +0.00%, compared to ARGNF's ROE of +0.22%. Regarding short-term risk, FPHAF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
FPHAF vs WXIBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXIBF has a market cap of 21.7B. Regarding current trading prices, FPHAF is priced at $3.30, while WXIBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXIBF's P/E ratio is 37.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to WXIBF's ROE of +0.10%. Regarding short-term risk, FPHAF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
FPHAF vs WXXWY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXXWY has a market cap of 21.4B. Regarding current trading prices, FPHAF is priced at $3.30, while WXXWY trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXXWY's P/E ratio is 37.63. In terms of profitability, FPHAF's ROE is +0.00%, compared to WXXWY's ROE of +0.10%. Regarding short-term risk, FPHAF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check WXXWY's competition here
FPHAF vs IVBXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVBXF has a market cap of 19.8B. Regarding current trading prices, FPHAF is priced at $3.30, while IVBXF trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVBXF's P/E ratio is 115.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to IVBXF's ROE of +0.08%. Regarding short-term risk, FPHAF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IVBXF's competition here
FPHAF vs GNMSF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNMSF has a market cap of 17.5B. Regarding current trading prices, FPHAF is priced at $3.30, while GNMSF trades at $284.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNMSF's P/E ratio is 12.46. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNMSF's ROE of +0.14%. Regarding short-term risk, FPHAF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
FPHAF vs SBMFF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBMFF has a market cap of 15B. Regarding current trading prices, FPHAF is priced at $3.30, while SBMFF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBMFF's P/E ratio is 28.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to SBMFF's ROE of +0.12%. Regarding short-term risk, FPHAF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
FPHAF vs SBHMY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, FPHAF is priced at $3.30, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBHMY's P/E ratio is 25.63. In terms of profitability, FPHAF's ROE is +0.00%, compared to SBHMY's ROE of +0.12%. Regarding short-term risk, FPHAF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
FPHAF vs AAVXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAVXF has a market cap of 9.9B. Regarding current trading prices, FPHAF is priced at $3.30, while AAVXF trades at $125.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAVXF's P/E ratio is -24.03. In terms of profitability, FPHAF's ROE is +0.00%, compared to AAVXF's ROE of +50.78%. Regarding short-term risk, FPHAF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
FPHAF vs BRRGF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, FPHAF is priced at $3.30, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRRGF's P/E ratio is -47.60. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRRGF's ROE of -1.05%. Regarding short-term risk, FPHAF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRRGF's competition here
FPHAF vs ODTC Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, FPHAF is priced at $3.30, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ODTC's P/E ratio is 1.07. In terms of profitability, FPHAF's ROE is +0.00%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, FPHAF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
FPHAF vs AKBLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AKBLF has a market cap of 7.3B. Regarding current trading prices, FPHAF is priced at $3.30, while AKBLF trades at $36.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AKBLF's P/E ratio is 45.70. In terms of profitability, FPHAF's ROE is +0.00%, compared to AKBLF's ROE of +0.19%. Regarding short-term risk, FPHAF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
FPHAF vs TRSBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRSBF has a market cap of 6.2B. Regarding current trading prices, FPHAF is priced at $3.30, while TRSBF trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRSBF's P/E ratio is 18.71. In terms of profitability, FPHAF's ROE is +0.00%, compared to TRSBF's ROE of +0.15%. Regarding short-term risk, FPHAF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
FPHAF vs REGMF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, FPHAF is priced at $3.30, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas REGMF's P/E ratio is -31.65. In terms of profitability, FPHAF's ROE is +0.00%, compared to REGMF's ROE of -0.45%. Regarding short-term risk, FPHAF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
FPHAF vs ABCZF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, FPHAF is priced at $3.30, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, FPHAF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
FPHAF vs LABFF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, FPHAF is priced at $3.30, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas LABFF's P/E ratio is 28.95. In terms of profitability, FPHAF's ROE is +0.00%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, FPHAF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
FPHAF vs ZLDPF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, FPHAF is priced at $3.30, while ZLDPF trades at $60.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ZLDPF's P/E ratio is 4.18. In terms of profitability, FPHAF's ROE is +0.00%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, FPHAF and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
FPHAF vs SHJBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SHJBF has a market cap of 4.1B. Regarding current trading prices, FPHAF is priced at $3.30, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SHJBF's P/E ratio is -20.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to SHJBF's ROE of -0.16%. Regarding short-term risk, FPHAF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
FPHAF vs GNNSF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, FPHAF is priced at $3.30, while GNNSF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNNSF's P/E ratio is -43.75. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNNSF's ROE of +0.71%. Regarding short-term risk, FPHAF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GNNSF's competition here
FPHAF vs CAMRF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, FPHAF is priced at $3.30, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CAMRF's P/E ratio is 40.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, FPHAF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
FPHAF vs BRCTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRCTF has a market cap of 3.4B. Regarding current trading prices, FPHAF is priced at $3.30, while BRCTF trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRCTF's P/E ratio is 30.16. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRCTF's ROE of +0.59%. Regarding short-term risk, FPHAF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRCTF's competition here
FPHAF vs ASPHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, FPHAF is priced at $3.30, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASPHF's P/E ratio is -16.31. In terms of profitability, FPHAF's ROE is +0.00%, compared to ASPHF's ROE of -1.40%. Regarding short-term risk, FPHAF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
FPHAF vs INCPF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, FPHAF is priced at $3.30, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INCPF's P/E ratio is -102.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to INCPF's ROE of -0.03%. Regarding short-term risk, FPHAF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
FPHAF vs MPSYF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, FPHAF's ROE is +0.00%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, FPHAF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MPSYF's competition here
FPHAF vs TLPPF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TLPPF has a market cap of 2.6B. Regarding current trading prices, FPHAF is priced at $3.30, while TLPPF trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TLPPF's P/E ratio is 384.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to TLPPF's ROE of +0.07%. Regarding short-term risk, FPHAF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TLPPF's competition here
FPHAF vs GENSF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GENSF has a market cap of 2.5B. Regarding current trading prices, FPHAF is priced at $3.30, while GENSF trades at $37.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GENSF's P/E ratio is 95.51. In terms of profitability, FPHAF's ROE is +0.00%, compared to GENSF's ROE of +0.04%. Regarding short-term risk, FPHAF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
FPHAF vs BVNRY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNRY trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNRY's P/E ratio is 6.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to BVNRY's ROE of +0.20%. Regarding short-term risk, FPHAF and BVNRY have similar daily volatility (0.00).Check BVNRY's competition here
FPHAF vs BVNKF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNKF's P/E ratio is 6.24. In terms of profitability, FPHAF's ROE is +0.00%, compared to BVNKF's ROE of +0.20%. Regarding short-term risk, FPHAF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
FPHAF vs GLPGF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, FPHAF is priced at $3.30, while GLPGF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GLPGF's P/E ratio is -4.24. In terms of profitability, FPHAF's ROE is +0.00%, compared to GLPGF's ROE of -0.16%. Regarding short-term risk, FPHAF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
FPHAF vs ASCLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, FPHAF is priced at $3.30, while ASCLF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASCLF's P/E ratio is -56.37. In terms of profitability, FPHAF's ROE is +0.00%, compared to ASCLF's ROE of -0.13%. Regarding short-term risk, FPHAF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ASCLF's competition here
FPHAF vs MEOBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, FPHAF is priced at $3.30, while MEOBF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MEOBF's P/E ratio is -15.90. In terms of profitability, FPHAF's ROE is +0.00%, compared to MEOBF's ROE of -0.19%. Regarding short-term risk, FPHAF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MEOBF's competition here
FPHAF vs ONTTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ONTTF has a market cap of 1.9B. Regarding current trading prices, FPHAF is priced at $3.30, while ONTTF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ONTTF's P/E ratio is -9.80. In terms of profitability, FPHAF's ROE is +0.00%, compared to ONTTF's ROE of -0.26%. Regarding short-term risk, FPHAF and ONTTF have similar daily volatility (0.00).Check ONTTF's competition here
FPHAF vs BIESF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, FPHAF is priced at $3.30, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BIESF's P/E ratio is -44.44. In terms of profitability, FPHAF's ROE is +0.00%, compared to BIESF's ROE of -0.07%. Regarding short-term risk, FPHAF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
FPHAF vs PHMMF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHMMF has a market cap of 1.5B. Regarding current trading prices, FPHAF is priced at $3.30, while PHMMF trades at $88.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHMMF's P/E ratio is 38.57. In terms of profitability, FPHAF's ROE is +0.00%, compared to PHMMF's ROE of +0.17%. Regarding short-term risk, FPHAF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
FPHAF vs HBMHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, FPHAF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
FPHAF vs SNBIF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, FPHAF's ROE is +0.00%, compared to SNBIF's ROE of -2.53%. Regarding short-term risk, FPHAF and SNBIF have similar daily volatility (0.00).Check SNBIF's competition here
FPHAF vs IDRSF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IDRSF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while IDRSF trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IDRSF's P/E ratio is -6.42. In terms of profitability, FPHAF's ROE is +0.00%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, FPHAF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
FPHAF vs CSBTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while CSBTF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSBTF's P/E ratio is -160.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSBTF's ROE of -0.08%. Regarding short-term risk, FPHAF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
FPHAF vs NURPF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NURPF has a market cap of 1.2B. Regarding current trading prices, FPHAF is priced at $3.30, while NURPF trades at $8.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NURPF's P/E ratio is 12.32. In terms of profitability, FPHAF's ROE is +0.00%, compared to NURPF's ROE of +0.43%. Regarding short-term risk, FPHAF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
FPHAF vs CSPHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, FPHAF is priced at $3.30, while CSPHF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSPHF's P/E ratio is -20.01. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSPHF's ROE of -0.71%. Regarding short-term risk, FPHAF and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here
FPHAF vs MDCLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, FPHAF is priced at $3.30, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, FPHAF's ROE is +0.00%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, FPHAF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
FPHAF vs PPTDF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while PPTDF trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PPTDF's P/E ratio is -35.40. In terms of profitability, FPHAF's ROE is +0.00%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, FPHAF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
FPHAF vs PHGUF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while PHGUF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHGUF's P/E ratio is -160.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to PHGUF's ROE of +0.00%. Regarding short-term risk, FPHAF and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here
FPHAF vs BTTAY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, FPHAF is priced at $3.30, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, FPHAF's ROE is +0.00%, compared to BTTAY's ROE of -0.07%. Regarding short-term risk, FPHAF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BTTAY's competition here
FPHAF vs TKBIF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, FPHAF is priced at $3.30, while TKBIF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TKBIF's P/E ratio is -20.86. In terms of profitability, FPHAF's ROE is +0.00%, compared to TKBIF's ROE of N/A. Regarding short-term risk, FPHAF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
FPHAF vs BPMUF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BPMUF has a market cap of 871.3M. Regarding current trading prices, FPHAF is priced at $3.30, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, FPHAF's ROE is +0.00%, compared to BPMUF's ROE of +0.44%. Regarding short-term risk, FPHAF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
FPHAF vs INRLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INRLF has a market cap of 833.8M. Regarding current trading prices, FPHAF is priced at $3.30, while INRLF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INRLF's P/E ratio is -6.29. In terms of profitability, FPHAF's ROE is +0.00%, compared to INRLF's ROE of -0.59%. Regarding short-term risk, FPHAF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
FPHAF vs VBIZF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, FPHAF is priced at $3.30, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, FPHAF's ROE is +0.00%, compared to VBIZF's ROE of +0.04%. Regarding short-term risk, FPHAF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
FPHAF vs IVEVF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVEVF has a market cap of 617.4M. Regarding current trading prices, FPHAF is priced at $3.30, while IVEVF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVEVF's P/E ratio is -1.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to IVEVF's ROE of +5.38%. Regarding short-term risk, FPHAF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check IVEVF's competition here
FPHAF vs CKDXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, FPHAF is priced at $3.30, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, FPHAF's ROE is +0.00%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, FPHAF and CKDXF have similar daily volatility (0.00).Check CKDXF's competition here
FPHAF vs SOLTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SOLTF has a market cap of 492.3M. Regarding current trading prices, FPHAF is priced at $3.30, while SOLTF trades at $5.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SOLTF's P/E ratio is -23.65. In terms of profitability, FPHAF's ROE is +0.00%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, FPHAF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
FPHAF vs GNFTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNFTF has a market cap of 461M. Regarding current trading prices, FPHAF is priced at $3.30, while GNFTF trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNFTF's P/E ratio is -9.95. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNFTF's ROE of -0.64%. Regarding short-term risk, FPHAF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
FPHAF vs RAONF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, FPHAF is priced at $3.30, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas RAONF's P/E ratio is -43.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, FPHAF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check RAONF's competition here
FPHAF vs GNFTY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, FPHAF is priced at $3.30, while GNFTY trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNFTY's P/E ratio is -9.62. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, FPHAF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GNFTY's competition here
FPHAF vs BOVNF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, FPHAF is priced at $3.30, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, FPHAF's ROE is +0.00%, compared to BOVNF's ROE of -0.41%. Regarding short-term risk, FPHAF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BOVNF's competition here
FPHAF vs TBGNF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, FPHAF is priced at $3.30, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, FPHAF's ROE is +0.00%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, FPHAF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
FPHAF vs CLVLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, FPHAF's ROE is +0.00%, compared to CLVLF's ROE of +0.16%. Regarding short-term risk, FPHAF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
FPHAF vs CLVLY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLY has a market cap of 416.7M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLY trades at $8.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLY's P/E ratio is 16.27. In terms of profitability, FPHAF's ROE is +0.00%, compared to CLVLY's ROE of +0.16%. Regarding short-term risk, FPHAF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CLVLY's competition here
FPHAF vs PTCHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PTCHF has a market cap of 410.4M. Regarding current trading prices, FPHAF is priced at $3.30, while PTCHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PTCHF's P/E ratio is 9.99. In terms of profitability, FPHAF's ROE is +0.00%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, FPHAF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
FPHAF vs NWBO Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWBO has a market cap of 369.9M. Regarding current trading prices, FPHAF is priced at $3.30, while NWBO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWBO's P/E ratio is -4.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, FPHAF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NWBO's competition here
FPHAF vs PRRUF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PRRUF has a market cap of 368M. Regarding current trading prices, FPHAF is priced at $3.30, while PRRUF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PRRUF's P/E ratio is -8.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to PRRUF's ROE of -0.27%. Regarding short-term risk, FPHAF and PRRUF have similar daily volatility (0.00).Check PRRUF's competition here
FPHAF vs AVCTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AVCTF has a market cap of 349.9M. Regarding current trading prices, FPHAF is priced at $3.30, while AVCTF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AVCTF's P/E ratio is -5.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, FPHAF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
FPHAF vs NGENF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NGENF has a market cap of 339.8M. Regarding current trading prices, FPHAF is priced at $3.30, while NGENF trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NGENF's P/E ratio is -16.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, FPHAF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NGENF's competition here
FPHAF vs CYDY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CYDY has a market cap of 326.7M. Regarding current trading prices, FPHAF is priced at $3.30, while CYDY trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CYDY's P/E ratio is -8.57. In terms of profitability, FPHAF's ROE is +0.00%, compared to CYDY's ROE of +0.38%. Regarding short-term risk, FPHAF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CYDY's competition here
FPHAF vs CMVLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMVLF has a market cap of 325.5M. Regarding current trading prices, FPHAF is priced at $3.30, while CMVLF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMVLF's P/E ratio is -13.64. In terms of profitability, FPHAF's ROE is +0.00%, compared to CMVLF's ROE of -0.32%. Regarding short-term risk, FPHAF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
FPHAF vs SPHDF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHDF has a market cap of 294.9M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHDF trades at $21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHDF's P/E ratio is -3.03. In terms of profitability, FPHAF's ROE is +0.00%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, FPHAF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
FPHAF vs PBBIF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, FPHAF's ROE is +0.00%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, FPHAF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
FPHAF vs FGHQF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, FGHQF has a market cap of 283.9M. Regarding current trading prices, FPHAF is priced at $3.30, while FGHQF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas FGHQF's P/E ratio is 14.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to FGHQF's ROE of +0.01%. Regarding short-term risk, FPHAF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
FPHAF vs ORPOF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, FPHAF is priced at $3.30, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, FPHAF's ROE is +0.00%, compared to ORPOF's ROE of N/A. Regarding short-term risk, FPHAF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
FPHAF vs HNSBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HNSBF has a market cap of 246.6M. Regarding current trading prices, FPHAF is priced at $3.30, while HNSBF trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HNSBF's P/E ratio is -2.88. In terms of profitability, FPHAF's ROE is +0.00%, compared to HNSBF's ROE of +1.24%. Regarding short-term risk, FPHAF and HNSBF have similar daily volatility (0.00).Check HNSBF's competition here
FPHAF vs HLOSF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HLOSF has a market cap of 243M. Regarding current trading prices, FPHAF is priced at $3.30, while HLOSF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HLOSF's P/E ratio is -5.38. In terms of profitability, FPHAF's ROE is +0.00%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, FPHAF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
FPHAF vs OPORF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, FPHAF is priced at $3.30, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas OPORF's P/E ratio is 35.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to OPORF's ROE of +0.12%. Regarding short-term risk, FPHAF and OPORF have similar daily volatility (0.00).Check OPORF's competition here
FPHAF vs NWPHF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWPHF has a market cap of 239.5M. Regarding current trading prices, FPHAF is priced at $3.30, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWPHF's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, FPHAF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
FPHAF vs ORYZF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ORYZF has a market cap of 238.9M. Regarding current trading prices, FPHAF is priced at $3.30, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ORYZF's P/E ratio is -75.75. In terms of profitability, FPHAF's ROE is +0.00%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, FPHAF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
FPHAF vs SLNCF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, FPHAF is priced at $3.30, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SLNCF's P/E ratio is -3.56. In terms of profitability, FPHAF's ROE is +0.00%, compared to SLNCF's ROE of -1.32%. Regarding short-term risk, FPHAF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
FPHAF vs VSBC Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, FPHAF is priced at $3.30, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas VSBC's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to VSBC's ROE of +10.17%. Regarding short-term risk, FPHAF and VSBC have similar daily volatility (0.00).Check VSBC's competition here
FPHAF vs SCNLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SCNLF has a market cap of 200.1M. Regarding current trading prices, FPHAF is priced at $3.30, while SCNLF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SCNLF's P/E ratio is -19.28. In terms of profitability, FPHAF's ROE is +0.00%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, FPHAF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SCNLF's competition here
FPHAF vs IPHYF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IPHYF has a market cap of 186.5M. Regarding current trading prices, FPHAF is priced at $3.30, while IPHYF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IPHYF's P/E ratio is -3.06. In terms of profitability, FPHAF's ROE is +0.00%, compared to IPHYF's ROE of -6.59%. Regarding short-term risk, FPHAF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
FPHAF vs KNTPF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, KNTPF has a market cap of 184M. Regarding current trading prices, FPHAF is priced at $3.30, while KNTPF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas KNTPF's P/E ratio is -6.54. In terms of profitability, FPHAF's ROE is +0.00%, compared to KNTPF's ROE of -0.35%. Regarding short-term risk, FPHAF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
FPHAF vs BBIXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BBIXF has a market cap of 175.2M. Regarding current trading prices, FPHAF is priced at $3.30, while BBIXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BBIXF's P/E ratio is -15.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to BBIXF's ROE of -8.24%. Regarding short-term risk, FPHAF and BBIXF have similar daily volatility (0.00).Check BBIXF's competition here
FPHAF vs MSCLF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MSCLF has a market cap of 174.1M. Regarding current trading prices, FPHAF is priced at $3.30, while MSCLF trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MSCLF's P/E ratio is 4.38. In terms of profitability, FPHAF's ROE is +0.00%, compared to MSCLF's ROE of -0.52%. Regarding short-term risk, FPHAF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MSCLF's competition here
FPHAF vs RECEF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, RECEF has a market cap of 174M. Regarding current trading prices, FPHAF is priced at $3.30, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas RECEF's P/E ratio is -8.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to RECEF's ROE of +5.33%. Regarding short-term risk, FPHAF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check RECEF's competition here
FPHAF vs ADOCY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, FPHAF is priced at $3.30, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, FPHAF's ROE is +0.00%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, FPHAF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
FPHAF vs SPHRY Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHRY has a market cap of 150.3M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHRY trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHRY's P/E ratio is -59.67. In terms of profitability, FPHAF's ROE is +0.00%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, FPHAF and SPHRY have similar daily volatility (0.00).Check SPHRY's competition here
FPHAF vs AMGXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AMGXF has a market cap of 139.1M. Regarding current trading prices, FPHAF is priced at $3.30, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, FPHAF's ROE is +0.00%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, FPHAF and AMGXF have similar daily volatility (0.00).Check AMGXF's competition here
FPHAF vs BRIBF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, FPHAF is priced at $3.30, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRIBF's P/E ratio is -2.69. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRIBF's ROE of -0.07%. Regarding short-term risk, FPHAF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
FPHAF vs HBPCF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, FPHAF is priced at $3.30, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HBPCF's P/E ratio is -34.60. In terms of profitability, FPHAF's ROE is +0.00%, compared to HBPCF's ROE of -0.65%. Regarding short-term risk, FPHAF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
FPHAF vs TRGNF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRGNF has a market cap of 132.1M. Regarding current trading prices, FPHAF is priced at $3.30, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, FPHAF's ROE is +0.00%, compared to TRGNF's ROE of -6.34%. Regarding short-term risk, FPHAF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TRGNF's competition here
FPHAF vs MLLCF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MLLCF has a market cap of 130.9M. Regarding current trading prices, FPHAF is priced at $3.30, while MLLCF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MLLCF's P/E ratio is -1.67. In terms of profitability, FPHAF's ROE is +0.00%, compared to MLLCF's ROE of -0.51%. Regarding short-term risk, FPHAF and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
FPHAF vs JWCTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, JWCTF has a market cap of 127.5M. Regarding current trading prices, FPHAF is priced at $3.30, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas JWCTF's P/E ratio is -1.46. In terms of profitability, FPHAF's ROE is +0.00%, compared to JWCTF's ROE of -0.59%. Regarding short-term risk, FPHAF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
FPHAF vs AAPGV Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, FPHAF is priced at $3.30, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAPGV's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to AAPGV's ROE of -2.49%. Regarding short-term risk, FPHAF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AAPGV's competition here
FPHAF vs PSTTF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, FPHAF is priced at $3.30, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to PSTTF's ROE of N/A. Regarding short-term risk, FPHAF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
FPHAF vs NDTP Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NDTP has a market cap of 113.6M. Regarding current trading prices, FPHAF is priced at $3.30, while NDTP trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NDTP's P/E ratio is -2.22. In terms of profitability, FPHAF's ROE is +0.00%, compared to NDTP's ROE of -0.24%. Regarding short-term risk, FPHAF and NDTP have similar daily volatility (0.00).Check NDTP's competition here
FPHAF vs PRNAF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PRNAF has a market cap of 109.8M. Regarding current trading prices, FPHAF is priced at $3.30, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PRNAF's P/E ratio is -1.01. In terms of profitability, FPHAF's ROE is +0.00%, compared to PRNAF's ROE of -0.38%. Regarding short-term risk, FPHAF and PRNAF have similar daily volatility (0.00).Check PRNAF's competition here
FPHAF vs EPRXF Comparison February 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, FPHAF is priced at $3.30, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, FPHAF's ROE is +0.00%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, FPHAF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check EPRXF's competition here